Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2025 08:00 ET | Source: Glucose Health

Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors

BENTONVILLE, Ark., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced a further strengthening of its Board of Directors with the appointment of Christopher J....
October 28, 2025 10:30 ET | Source: Heald

Former Amazon Care Executive Dr. Sunita Mishra Joins Heald’s Advisory Board to Accelerate Expansion Across Employers and Provider Networks

ALPHARETTA, Ga., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Heald, the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief Medical Officer of...
October 23, 2025 08:00 ET | Source: Glucose Health

Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors

BENTONVILLE, Ark., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services...
October 21, 2025 08:00 ET | Source: Glucose Health

Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook

BENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of...
August 14, 2025 16:00 ET | Source: Heald

Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal

ALPHARETTA, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Heald, a pioneering digital health company specializing in Type 2 diabetes reversal through personalized lifestyle interventions, today announced a...
June 29, 2022 09:40 ET | Source: Straits Research

Diabetes Care Devices Market Size is projected to reach USD 87.15 Billion by 2030, growing at a CAGR of 6%: Straits Research

New York, United States, June 29, 2022 (GLOBE NEWSWIRE) -- Diabetes is a life-threatening, chronic disorder for which there is no treatment. Diabetes is becoming a global pandemic affecting millions...
December 09, 2021 09:00 ET | Source: Renova Therapeutics

Renova Therapeutics Appoints Dr. Vijay Mahant as Its CEO

CARLSBAD, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Dr. Mahant brings a wealth of knowledge and experience to his role as the CEO. He is a scientist, an inventor (awarded 32 international patents)...